Anivance AI Corporation
Update：2026/10/27
Industries
Main Industry
Biotechnology
Main Product/Service
1. Organ Core™ Modular Organ-on-a-Chip Platform: Engineering-grade organ-on-a-chip modules covering a wide range of organs with disease-modeling capabilities and comparable input/output standards.
2. High-Throughput and Sensor-Integrated Chip Modules: Supports simultaneous testing of multiple samples, integrates electrodes and real-time sensing, and provides reproducible and quantifiable data.
3. Automated Inhalation and Dynamic Air-Liquid Circulation System: Air-liquid circulation and micro-inhalation exposure modules for the evaluation of respiratory tract and inhaled drugs/nanoparticles.
4. Human Data Foundry™ Analysis Software: Provides image analysis, kinetic tracking, and experimental analysis workflows.
(The content above was translated by AI.)
2. High-Throughput and Sensor-Integrated Chip Modules: Supports simultaneous testing of multiple samples, integrates electrodes and real-time sensing, and provides reproducible and quantifiable data.
3. Automated Inhalation and Dynamic Air-Liquid Circulation System: Air-liquid circulation and micro-inhalation exposure modules for the evaluation of respiratory tract and inhaled drugs/nanoparticles.
4. Human Data Foundry™ Analysis Software: Provides image analysis, kinetic tracking, and experimental analysis workflows.
(The content above was translated by AI.)
Founded Year
2024
Unified Business No.
95464296
Status
Active
Number of Employees
20
Total Paid-in
Capital
34,130,000 (NT$)
Location of Company
Taiwan
, Hsinchu County
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Anivance AI is transforming biomedical research by integrating organ-on-a-chip technology with human data-driven AI. Its platform combines human organ chips and advanced computational modeling to create digital twins, providing an alternative to traditional animal testing. By using patient-derived cells to build micro-organs, the system enables highly personalized simulation of drug responses. This approach improves predictive accuracy, shortens drug development timelines, and supports more ethical, data-driven research. By bridging biology and artificial intelligence, Anivance AI is positioning itself as a next-generation medical testing platform for precision medicine and pharmaceutical innovation.
